H/2813 - Purchase, Importation, Storage, QP certification, Distribution and Labelling of Drug for Clinical Trial
The Clinical Trial Research Unit at the University of Leeds is seeking tenders for the Purchase, importation, distribution, storage, labelling and QP release of a drug for a clinical trial. The Clinical Trial is called ReoGlio and it is looking at a new treatment combination in adult patients with glioblastoma multiforme. The two medicinal products to be used in combination are the reovirus (REOLYSIN®) and GM-CSF which will be given alongside the standard of care chemoradiotherapy (6 weeks) and adjuvant chemothera...
Buyer
UNIVERSITY OF LEEDS
Value
Not provided
Published
8 Mar 2017
Closes
7 Apr 2017
Procurement details
Source
Contracts Finder
Region
Leeds
Procurement method
Open
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
73000000
Research and development services and related consultancy services
Lots
Lot default H/2813 - Purchase, Importation, Storage, QP certification, Distribution and Labelling of Drug for Clinical Trial
Value not provided
The Clinical Trial Research Unit at the University of Leeds is seeking tenders for the Purchase, importation, distribution, storage, labelling and QP release of a drug for a clinical trial. The Clinical Trial is called ReoGlio and it is looking at a new treatment combination in adult patients with glioblastoma multiforme. The two medicinal products to be use...
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
8 Mar 2017
Opportunity notice on Contracts Finder
Tender notice · Web page
Additional information on how to apply for this contract
Not provided
Additional information on how to apply for this contract
Tender notice
Contains public sector information licensed under the Open Government Licence v3.0.